“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India” - Top-Institutions - MDSpire

“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India”

  • By

  • Amey Oak

  • Sandhya Cheulkar

  • Sivaranjini K.

  • Riya John

  • Meghaj Jadhav

  • Dhanvi Patil

  • Esha Dashmukhe

  • Ashwini Patil

  • Sachin Wankhade

  • Pragati Gode

  • Aijimol Thakadiyil

  • Ganesh Balasubramanium

  • Gauravi Mishra

  • Rajesh Dikshit

  • Pankaj Chaturvedi

  • Sudeep Gupta

  • June 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Tata Memorial Centre
    Tata Memorial Centre

    Mumbai, Maharashtra

    Key Differentiators

    • Oncology

  • #2

    Advanced Centre for Treatment, Research and Education in Cancer
    Advanced Centre for Treatment, Research and Education in Cancer

    Mumbai, Maharashtra

    Key Differentiators

    • Oncology

  • #3

    Apollo Cancer Centre
    Apollo Cancer Centre

    New Delhi, Delhi

    Key Differentiators

    • Oncology

  • #4

    University of Minnesota
    University of Minnesota

    Minneapolis, Minnesota

    Key Differentiators

    • Oncology

  • #5

    Moffitt Cancer Center
    Moffitt Cancer Center

    Tampa, Florida

    Key Differentiators

    • Oncology

Original Source(s)

“Assessment of an EMR-integrated Onco-Insight hospital-based cancer registry system for data completeness and data entry turnaround time at a tertiary care cancer center in India”

  • by Amey Oak, Sandhya Cheulkar, Sivaranjini K., Riya John, Meghaj Jadhav, Dhanvi Patil, Esha Dashmukhe, Ashwini Patil, Sachin Wankhade, Pragati Gode, Aijimol Thakadiyil, Ganesh Balasubramanium, Gauravi Mishra, Rajesh Dikshit, Pankaj Chaturvedi, Sudeep Gupta

  • June 9, 2026

Related Content

Angiosarcoma in a soft tissue sarcoma cohort: real-world patterns and outcomes

This Week’s CGT News: Promising Data for In Vivo CAR T

Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts

  • June 8, 2026

  • 6 min
Radiogenomics and the DNA damage response: opportunities for biomarker-guided radiosensitization in pancreatic cancer